Amedisys (AMED) Tops Q1 EPS by 12c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Salaries and benefits: 77.02M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Salaries and benefits: 77.02M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q1 EPS of $0.79, $0.12 better than the analyst estimate of $0.67. Revenue for the quarter came in at $399.3 million versus the consensus estimate of $395.28 million.
GUIDANCE:
Amedisys sees FY2018 EPS of $2.97-$3.08, versus the consensus of $3.00. Amedisys sees FY2018 revenue of $1.6-1.64 million, versus the consensus of $1.63 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
- Federal Realty Inv. Trust (FRT) Tops Q3 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
